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Pattern formationtiple KH-domain RNA-binding protein required for Drosophila oogenesis and,
maternally, for embryonic patterning. In early oogenesis, Bic-C negatively regulates target mRNAs, including
Bic-C, by recruiting the CCR4 deadenylase through a direct association with its NOT3 subunit. Here, we
identify a novel function for Bic-C in secretion of the TGF-α homolog Gurken (Grk). In Bic-C mutant egg
chambers, Grk is sequestered within actin-coated structures during mid-oogenesis. As a consequence, Egfr
signalling is not efﬁciently activated in the dorsal-anterior follicle cells. This phenotype is strikingly similar to
that of trailer hitch (tral) mutants. Consistent with the idea that Bic-C and Tral act together in Grk secretion,
Bic-C co-localizes with Tral within cytoplasmic granules, and can be co-puriﬁed with multiple protein
components of a Tral mRNP complex. Taken together, our results implicate translational regulation by Bic-C
and Tral in the secretory pathway.
© 2009 Elsevier Inc. All rights reserved.IntroductionThe anterior/posterior (A/P) and dorsal/ventral (D/V) axes of the
future embryo are both established during Drosophila oogenesis by
signalling events between the oocyte and the overlying somatic
follicle cells. These signals are mediated in part by the TGF-α
homologue Gurken (Grk), which is secreted from the oocyte to
activate the follicle cell-bound Epidermal Growth Factor receptor
(Egfr) (Gonzalez-Reyes et al., 1995). This initially occurs at stage 6,
when activation of Egfr in a posterior group of follicle cells triggers the
production of an unknown signal that establishes the A/P axis of the
oocyte. As a consequence, the microtubule cytoskeleton reorganizes
within the oocyte such that patterning determinants localize to
distinct sub-cellular domains. The oocyte nucleus, which is closely
associated with grk mRNA throughout most of oogenesis, migrates to
the anterior cortex in response to the cytoskeletal rearrangements at
stage 7. Localized Grk then speciﬁes the dorsal side of the oocyte
through a second round of Egfr activation in the anterior/lateral
follicle cells that are adjacent to the oocyte nucleus (Neuman-
Silberberg and Schupbach, 1993).
Grk is cleaved in the ER by the membrane-bound protease
Rhomboid 2, to produce the active, secreted form, which is then
tethered by Cornichon (Cni) (Ghiglione et al., 2002; Guichard et al.,cGill University and Genome
ld, Montréal, Québec, Canada
l rights reserved.2000). Cni is a transmembrane protein that acts as a cargo receptor,
recruiting Grk into COPII-coated vesicles for rapid export (Guichard
et al., 2000). An ER-associated ribonucleoprotein (RNP) complex,
containing Trailer Hitch (Tral), Maternal Expression at 31B (Me31B),
Ypsilon Schachtel (Yps), Poly(A) Binding Protein (PABP) and Cup, has
been implicated in themaintenance of COPII exit sites from the ER and
consequently for efﬁcient exocytosis of Grk and other secreted
proteins during oogenesis (Wilhelm et al., 2005).
Me31B is a DDX6-like DEAD-box ATP-dependent RNA helicase that
localizes to maternal RNPs called sponge bodies, where it is required
for translational silencing of multiple mRNAs including the pole plasm
determinant oskar (Nakamura et al., 2001). Me31B also co-localizes
with the mRNA decapping factors DCP1 and DCP2 in cytoplasmic foci
resembling processing bodies (P-bodies) (Lin et al., 2006). P-bodies are
sites of mRNA storage and/or decay, deﬁned by the absence of
ribosomes and translation factors (with the exception of eIF4E) and
the presence of several proteins involved in mRNA degradation
including DCP1 and DCP2, the 5′–3′ exonuclease XRN1, and the
deadenylase CCR4 (Anderson and Kedersha, 2006). Orthologues of
Me31B in S. cerevisiae (Dhh1), C. elegans (CGH-1), X. laevis (Xp54) and
mammals (RCK/p54), are also components of P-bodies and/or
contribute to translational silencing of maternal mRNAs (Weston
and Sommerville, 2006). Likewise, the human orthologue of Tral,
RAP55, is a component of P-bodies and plays a critical role in their
assembly (Yang et al., 2006). Like Me31B, both Xp54 and CGH-1
associate with the respective Yps and Tral orthologues in X. laevis and
C. elegans respectively, indicating that these proteins operate within
an evolutionarily conserved complex that likely performs similar
functions in divergent metazoan species (reviewed by Weston and
Sommerville, 2006).
Table 2
Maternal effect lethality in heterozygous Bic-C females is dominantly enhanced by a
reduction in Trailer Hitch
Maternal genotype n % Unhatched
tral(1)/+ 637 8.2
Df(tral)/+ 581 2.7
+/Bic-C(IIF34) 484 1.7
+/Bic-C(YC33) 490 3.7
tral(1)/Bic-C(IIF34) 715 19.9
Df(tral)/Bic-C(IIF34) 692 24.2
tral(1)/Bic-C(YC33) 722 29.9
Df(tral)/Bic-C(YC33) 723 23.4
161J.-M. Kugler et al. / Developmental Biology 328 (2009) 160–172Me31B was recovered in a yeast-two-hybrid screen for Bicaudal-C
(Bic-C) interacting proteins (Chicoine et al., 2007). Bic-C is a KH-type
RNA-binding protein that acts antagonistically to the CPEB-like
protein Orb to regulate cytoplasmic movements during oogenesis,
through recruitment of the CCR4-POP2-NOT deadenylase complex to
target transcripts (Chicoine et al., 2007). Like Me31B and Cup, Bic-C is
also required for translational repression of unlocalized oskar and
consequently anterior/posterior embryonic patterning (Nakamura
et al., 2001; Wilhelm et al., 2005; Saffman et al., 1998).
We report here that Bic-C associates with Me31B, Tral, PABP and
Cup during oogenesis and that, like Tral, Bic-C is required for efﬁcient
Grk secretion.
Results
Bic-C and cni interact genetically
Bic-C mutant females display a haplo-insufﬁcient maternal effect
phenotype inwhich a small percentage of the offspring embryos show
variable deformations that range from mild segmentation defects to
fully bicaudal (Mahone et al., 1995). As a consequence, a proportion of
these embryos fail to hatch into larvae. This phenotype is consistently
more severe when the mutant Bic-C allele is maternally derived
(compare the heterozygous Bic-C ﬂies in Tables 1 and 2). A screen for
dominant enhancers of this phenotype revealed a strong genetic
interaction between Bic-C and cni (Table 1). Embryos derived from
females bearing a mutant allele of Bic-C in trans to an allele of cni
display a synergistic reduction in viability as compared to embryos
produced by females mutant for only a single allele.
Gurken accumulates ectopically in Bic-C mutant oocytes
Because Cni is the cargo receptor for Grk during secretion
(Guichard et al., 2000), the genetic interaction between Bic-C and
cni led us to hypothesize that Bic-C might be involved in Grk secretion.
To test this, we monitored Grk distribution inwild-type (wt) and Bic-C
mutant ovaries (Fig. 1). In wt oocytes, Grk protein begins to
accumulate at the anterodorsal cortex, in close association with the
oocyte nucleus, at stage 7, where it remains through late stage 9
(Fig. 1A). Virtually no Grk is observed on the side of the oocyte nucleus
which faces the center of the oocyte. In clear contrast, Grk distribution
is signiﬁcantly altered in Bic-C mutant egg chambers during mid-
oogenesis (Fig. 1B). In Bic-C oocytes, Grk is not restricted to the
anterodorsal cortex, but surrounds the entire oocyte nucleus, clustered
in spheroid aggregates that also face the center of the oocyte.
grk mRNA localization is a highly regulated process, and is a
prerequisite for restricted local secretion of Grk protein to the
anterodorsal follicle cells (Herpers and Rabouille, 2004). To ascertain
whether aberrant grk mRNA localization might be the cause of the
abnormal distribution of Grk protein in Bic-C mutants, we simulta-
neously visualized grk mRNA and Grk protein. Both in wt and in Bic-C
mutant egg chambers, grkmRNA is closely associated with the oocyte
nuclear membrane at stage 9 (Figs. 1A, B). However, in Bic-C mutants
grk mRNA is concentrated primarily between the nucleus and the
anterior cortex of the oocyte. In wt oocytes, grk mRNA is primarily
enriched along the dorsal cortex, with less enrichment adjacent to theTable 1
Embryos derived from Bic-C cni transheterozygote females show reduced viability
Maternal genotype n % Unhatched
+/cni(KG00189) 288 1.0
+/cni(1) 288 4.2
Bic-C(YC33)/+ 482 20.1
Bic-C(YC33)/cni(KG00189) 900 41.1
Bic-C(YC33)/cni(1) 797 61.0nuclear membrane, closely mirroring the distribution of Grk protein.
Thus Bic-C may be involved in ﬁne-tuning of the grk mRNA
localization pattern. In Bic-Cmutant oocytes we observe only a partial
overlap between Grk protein and the site of transcript accumulation,
in that Grk protein accumulates in spheres that can be quite distant
from the site of grkmRNA accumulation. This supports the idea that a
defect occurring after translation is the major underlying cause of the
abnormal Grk distribution in Bic-C mutant oocytes.
Grk signaling is impaired in Bic-C oocytes
We next asked whether activation of the epidermal growth factor
receptor (Egfr) is compromised in Bic-C egg chambers. We compared
expression of mirr-lacZ, a marker for Egfr activation in the ante-
rodorsal follicle cells (Zhao et al., 2000), in ovaries either heterozygous
or homozygous for the strong Bic-CYC33 allele. Immunoﬂuorescent
labelling demonstrates that in Bic-C heterozygotes, Grk distribution
and mirr-lacZ expression are indistinguishable from wt (Fig. 1C and
data not shown). However, in homozygous Bic-CYC33 ovaries,mirr-lacZ
expression is greatly reduced (Fig. 1D). Therefore, the unusual
distribution of Grk in Bic-C oocytes correlates with a failure to
efﬁciently activate Egfr signalling. We consider it unlikely that this
results from the small effect of Bic-C mutations on grk mRNA
localization, as mutations in K10, squid and Hrb27C all cause more
profound disruptions of grk mRNA localization, yet do not block
secretion of active Grk to the follicle cells (Forlani et al., 1993; Goodrich
et al., 2004).
An essential step in Grk signalling is cleavage in the ER, by the
combined activities of Star and stet (also called rhomboid-2) (Ghiglione
et al., 2002; Bokel et al., 2005). To determine whether lack of Bic-C
blocks this processing step, we expressed a Myc-tagged version of Grk
in wt and Bic-CYC33 homozygous ovaries (Ghiglione et al., 2002).
Western blotting demonstrates the presence of both the uncleaved
Grk species as well as of the C-terminal cleavage remnant both in wt
and Bic-CYC33 ovaries (Fig. 1E). This indicates that the failure to activate
Egfr in the dorsoanterior follicle cells is not caused simply by a defect
in Grk cleavage.
Mislocalized Grk accumulates in F-actin-coated spheres
To further characterize the nature of the ectopic Grk foci, we
labelled wt and Bic-C mutant egg chambers with rhodamine-
phalloidin to visualize the F-actin cytoskeleton. In wt oocytes, F-actin
is predominantly found in tight association with the cell membranes
(Figs. 2A, B). In contrast, cortical F-actin often appears disorganized in
Bic-Cmutant oocytes and, unlike in wt controls, the oocyte frequently
separates from the overlying follicle cells during ﬁxation and staining
(Figs. 2C–E). Bic-C mutant oocytes additionally display spherical F-
actin-coated structures which are detectable as early as stage 6. These
spheres are initially found primarily along the anterior margin of the
oocyte. The structures increase both in size and number until egg
chambers cease developing at stage 10b and subsequently degenerate.
Many of the F-actin-coated spheres cluster around the oocyte nucleus.
Fig. 1. Bic-C is required for normal Grk localization and Egfr activation but not for grk mRNA localization. (A, B) Immunoﬂuorescence and ﬂuorescent mRNA in situ hybridizations
reveal the distribution of Grk protein (green) and grk mRNA (red) in wt (A) and Bic-C deﬁcient (B) ovaries. DNA is visualized by DAPI staining (blue). (C, D) Immunoﬂuorescence
illustrates Grk protein (red) and β-Gal (representative of Mirr, green) expression in a heterozygous control (C) and a homozygous (D) Bic-CYC33 mutant. Arrows mark the position of
the border cells, indicating that the egg chambers are equivalently staged at late stage 9 or early stage 10A. (E) Western blotting withα-Myc illustrates Grk-(Myc)6 cleavage in ovaries
from wt (lane 1) or homozygous Bic-CYC33 mutant females (lane 2). Molecular weight standards indicate size in kDa.
162 J.-M. Kugler et al. / Developmental Biology 328 (2009) 160–172Although the migration of the oocyte nucleus to the anterior/dorsal
cortex at stage 7/8 occurs normally in Bic-C mutants, the oocyte
nucleus is frequently found dissociated from the anterior cortex during
stages 9–10 (Fig. 2E). In these cases, many spheroid F-actin structures
remain closely associated with the detached nucleus.We have observed similar structures and ectopic Grk accumulation
in several independently derived Bic-C mutants (data not shown).
Furthermore, germline-speciﬁc expression of TAP-tagged Bic-C
(pUASP-TAP-Bic-C) prevents the accumulation of actin-coated
structures within the oocyte and rescues the centripetal follicle cell
163J.-M. Kugler et al. / Developmental Biology 328 (2009) 160–172migration defect characteristic of Bic-C mutants (Figs. 2F–H). These
results conﬁrm that lack of Bic-C activity in the germline underlies the
defects in microﬁlament organization in Bic-C oocytes.
Importantly, the F-actin spheres and the sites of ectopic Grk
accumulation overlap (Fig. 2I). Ectopic Grk foci facing the center of the
oocyte are always encapsulatedby F-actin.However,manyof the F-actin
spheres do not contain Grk, especially those that are more distant from
the oocyte nucleus. This argues that the ectopic accumulation of Grk is
not the primarycause for the formation of the F-actin-coated structures.
F-actin-coated spheres in Bic-C egg chambers contain a distinct set of
secretory proteins
The accumulation of Grk within F-actin-coated spheres in Bic-C
mutant oocytes suggests that Grk might be trapped in anFig. 2. Bic-Cmutants display defects in actin distribution and form aberrant actin-coated sphe
F-actin (red) inwt stage 6 and 9 (A) and stage 10 (B) egg chambers. In Bic-C deﬁcient egg cham
as stage 6 (C) and increase in both size and number through stage 9 (D), until egg chambers sta
and/or separates from the overlying follicle cells (E) and the oocyte nucleus (on) often dissocia
and F-actin are visualized by DAPI (blue) and phalloidin (red) staining in wt (F), Bic-CYC33 hom
that germline expression of TAP-Bic-C restores centripetal migration of the follicle cells in Bic
within the oocyte. (I) In Bic-C deﬁcient ovaries, the majority of Grk protein (green) is concent
nucleus. F-actin spheres further removed from the oocyte nucleus do not contain detectableaberrantly acting secretory compartment through which proteins
cannot transit. In this case, the F-actin spheres should include a
distinct subset of proteins that function in the exocytic pathway.
The relationship between Bic-C and Tral (discussed below)
prompted us to initially focus on markers for the endoplasmic
reticulum (ER). We imaged ﬁxed and live Bic-C mutant egg
chambers (and heterozygous control siblings) expressing available
GFP protein traps (Buszczak et al., 2007; Lighthouse et al., 2008)
that reveal the distribution of the translocon complex (Sec63-GFP),
ER chaperone proteins [disulﬁde isomerase (PDI-GFP) and Calreti-
culin (Crt-GFP)], ER membranes (Surf4-GFP), and COPII exit sites
(Sar1-GFP) (Wilhelm et al., 2005); and we additionally performed
immunocytochemistry using antibodies speciﬁc for the ER chaper-
ones BiP and Calnexin (Cln) and the ER resident protein Boca (Culi
and Mann, 2003).res, many of which contain Grk. Phalloidin staining illustrates the normal distribution of
bers, F-actin-coated structures accumulatewithin the anterior oocyte cytoplasm as early
rt to degenerate at stage 10 (E). Also note that the oocyte cortex is often disorganized (D)
tes from the anterior dorsal cortex. DNA is visualized by DAPI staining (blue). (F–H) DNA
ozygotes (G) and BicYC33 homozygotes with germline expression of TAP-Bic-C (H). Note
YC33 homozygotes at stage 10B and prevents the formation of F-actin-coated aggregates
rated within a subset of the F-actin-coated structures (red), located closest to the oocyte
amounts of Grk.
164 J.-M. Kugler et al. / Developmental Biology 328 (2009) 160–172During mid-oogenesis, we observed essentially no germ line
expression of Surf4-GFP while we observed a prominent signal in
the follicular epithelium and in the border cells (data not shown). We
therefore did not further analyze this marker. In ﬁxed ovary samples,
Sec63-GFP, PDI-GFP and Crt-GFP all form a particulate pattern
throughout Bic-C/+ oocytes (Fig. 3 and data not shown). In ﬁxed
Bic-C mutant egg chambers, this pattern is not substantially altered.
We did not observe enrichment of these markers within the actin-
coated spheres; in fact, the signal intensity for these markers was
often diminished within the actin-coated spheres (Fig. 3B; and data
not shown). Only Crt-GFP was occasionally present in the actin-coated
structures during mid-oogenesis (Figs. 3C, D). The exclusion of Sec63-
GFP, PDI-GFP, and Crt-GFP from the F-actin-coated spheres was
conﬁrmed by live imaging, where we observed prominent spherical
gaps in the distribution of all three markers in a Bic-C mutant
background (Figs. 3F, H and data not shown). We believe these gaps
correspond to the actin-coated structures because they initially form
in the anterior of the oocyte, increase in size as oogenesis progresses
and frequently remain tightly associated with the detaching oocyteFig. 3. SomeERmarkers are excluded from the actin-coated spheres in Bic-C oocytes. (A–D) Fix
and homozygousBic-CYC33mutant (B, D) egg chambers. Crt-GFP is not enriched in F-actin spher
GFP is sometimes present inside the actin-coated structures (D, see arrows). (E–H) Live image
Bic-CYC33 (F, H) mutant ovaries. Both markers are excluded from spheroid structures in the an
from Bic-CYC33/+ (I) and homozygous Bic-CYC33 females labelled for Boca (green) and F-actin (nucleus. The distribution of Crt-GFP differed somewhat from those of
Sec63-GFP and PDI-GFP in that the former frequently decorated
spheroid structures at the posterior of Bic-C oocytes that we did not
observe in wt egg chambers or with any other GFP markers that we
utilized. Given their location, these Crt-GFP positive structures are
unlikely to correspond to the actin spheres. Very rarely, Sec63-GFP
formed bright foci in the anterior of younger Bic-C mutant oocytes
(data not shown). The ER luminal protein Boca also forms a particular
meshwork throughout the oocyte cytoplasm with some cortical
enrichment (Fig. 3I). In Bic-C mutant egg chambers, this pattern is
not strongly altered (Fig. 3J) and Boca is neither enriched within nor
excluded from the actin spheres.
The COPII exit site marker Sar1-GFP displayed a distribution
pattern that was strikingly different in control and Bic-C oocytes. In
heterozygous control oocytes, Sar1-GFP shows a particulate distribu-
tion with some cortical enrichment (Figs. 4A, C). In Bic-C mutant
oocytes, however, Sar1-GFP accumulates in foci that are located at the
anterior cortex near the nucleus (Figs. 4B, D). As egg chambersmature,
these foci become more prominent and increase in size and numbered tissue showing the distribution of Crt-GFP (green) and F-actin (red) in Bic-CYC33/+ (A, C)
es in theBic-Cmutant egg chambers during stages 9–10 (B). Inyounger Bic-C oocytes, Crt-
d ovaries expressing Crt-GFP (E, F) or PDI-GFP (G, H) in Bic-CYC33/+ (E, G) and homozygous
terior margin and that surround the oocyte nucleus in Bic-Cmutant oocytes. (I, J) Ovaries
red). Boca is neither enriched within, nor excluded from the actin spheres.
Fig. 4. Sar1-GFP accumulates in and around the actin-coated structures in Bic-Cmutants. Live imaged (A–D) andﬁxed (E, F) egg chambers expressing Sar1-GFP in a heterozygous (A, C, E)
or homozygous Bic-CYC33 mutant (B, D, F) background. In live imaged homozygous Bic-C mutant oocytes, luminous foci of Sar1-GFP accumulate at the anterior of the oocyte. In ﬁxed
samples, these foci clearly overlap with the actin-coated structures in Bic-C (F, see arrows).
165J.-M. Kugler et al. / Developmental Biology 328 (2009) 160–172near the anterior of the oocyte, while additional smaller Sar1-GFP foci
are observed throughout the oocyte cytoplasm at higher levels than in
control egg chambers. Since the size, appearance and localization of
these large Sar1-GFP foci closely resemble the F-actin-coated
structures, we stained ﬁxed samples with rhodamine-phalloidin to
determine if they co-localize. While much of the Sar1-GFP signal was
lost upon ﬁxation, a clear enrichment of Sar1-GFP in and around the F-
actin-coated structures is nevertheless visible (Figs. 4E, F). In contrast
to PDI-GFP and Crt-GFP, we observed a substantial enrichment of the
ER chaperones BiP and Cln in the actin-coated structures in Bic-C
oocytes (Fig. 5). α-BiP and α-Cln produce a particulate stainingpattern throughout Bic-C/+ oocytes that is enriched around the cortex
(Figs. 5A, C). In Bic-Cmutant oocytes, however, these two markers are
also clearly concentrated within the lumen of the actin spheres (Figs.
5B, D).
In summary, the actin-coated spheres contain Boca and are
enriched for COPII exit sites and for the ER chaperones BiP and Cln.
They however exclude other ER chaperones (PDI-GFP and Crt-GFP)
and the translocon complex component Sec63-GFP. This is consistent
with a defect in ER exit site formation in Bic-C mutants that affects a
speciﬁc subset of cargo vesicles destined for transport to the Golgi.
However, if the requirement for Bic-C activity is limited to ER exit site
Fig. 5. A subset of ER chaperones and the KDEL-receptor accumulate within the actin-coated spheres in Bic-C mutant oocytes. (A, B) Immunoﬂuorescent and rhodamine-phalloidin
staining illustrates Calnexin (green, see arrows) and F-actin (red) distribution inwt (A) and Bic-C deﬁcient (B) stage 9 egg chambers. (C, D) Fifteen 1 μMconfocal sections weremerged
to illustrate F-actin (red) and BiP (green) distribution in wt (C) and Bic-C deﬁcient (D) egg chambers. (E, F) The KDEL-receptor (green) is located throughout the cytoplasm of
heterozygous control (E) and homozygous mutant (F) Bic-CYC33 stage 8/9 egg chambers. In Bic-CYC33 homozygotes (F), KDEL-receptor is enriched in the actin-coated structures (red).
166 J.-M. Kugler et al. / Developmental Biology 328 (2009) 160–172formation, the actin spheres would be predicted not to contain
markers that characterize downstream membrane compartments in
the secretory pathway. To test this, we immunolabelled Bic-C
heterozygous and homozygous ovaries with an antibody raised
against a conserved sequence in the KDEL receptor (KDEL-R) which
is enriched at steady state in the cis-Golgi apparatus and mediates
retrograde transport of KDEL-containing proteins from the Golgi to
the ER (Pfeffer, 2007). In control egg chambers, α-KDEL-R produces aparticulate staining pattern throughout the cytoplasm of the oocyte
and the nurse cells (Fig. 5E). In addition, it labels structures within the
nurse cell nuclei which we assume to result from cross-reactivity. In
Bic-C mutant oocytes, however, α-KDEL-R signal is highly enriched
within and near the actin-coated spheres (Fig. 5F), indicating that this
cis-Golgi marker, like the ER markers discussed above, is associated
with these structures. We also labelled ovaries with an antibody
which detects the cis-Golgi marker protein GM130 (Abcam; Barr and
Fig. 6. A subset of Rab proteins and the exocyst component Sec5 are enriched in the actin-coated structures in Bic-C mutant oocytes. (A–H) Bic-CYC33 heterozygous controls (A, C, E, G) and homozygous Bic-CYC33 egg chambers (B, D, F, H) were
stained for F-actin (red) and immuno-stained (green) for: Rab11 (A, B), Rab5 (C, D), Rab7 (E, F), and Sec5 (G, H).
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Fig. 7. Bic-C associates withmultiple components of the Trailer Hitch/Me31B complex. (A) Me31B-eGFP ovarian immune complexeswere isolatedwithα-GFP, while IgGwas used as a
negative control. Complexes were probed withα-Bic-C (A, top panel) and α-Cup (A, bottom panel). (B) Bic-C immune complexes were isolated from ovaries expressing Me31B-eGFP,
while pre-immune sera served as a negative control. Co-precipitating proteins were probed with α-GFP. (C) Tral-GFP was immunoprecipitated with α-GFP from ovarian extracts and
co-precipitating proteins were probed with α-Bic-C. An equivalent amount of Oregon-R ovarian extract was used to control for Tral-independent binding. (D) Bic-C immune
complexes, isolated from Oregon-R ovarian extracts, were probed with α-Cup (D—top) and α-PABP (D—bottom). Pre-immune serum was used as a negative control.
168 J.-M. Kugler et al. / Developmental Biology 328 (2009) 160–172Short, 2003). The antibody produces a particulate staining pattern
throughout the oocyte cytoplasm with cortical enrichment in both
control and Bic-C mutant oocytes. We did not observe enrichment or
exclusion of this marker from the actin spheres (data not shown).
We next immunolabelled Bic-C heterozygous and homozygous
ovaries with antibodies that recognize Rab11 (Figs. 6A, B), which is
enriched in recycling endosomes (Tanaka and Nakamura, 2008), the
early endosomal marker Rab5 (Figs. 6C, D), and the late endosomal
marker Rab7 (Figs. 6E, F). In Bic-C heterozygous ovaries, all three
markers are found throughout the oocyte cytoplasm, with clear
enrichment at the oocyte cortex (Figs. 6A, C, E). Surprisingly, we found
that Rab11 and Rab5 were enriched within and near the actin-coated
spheres in Bic-CYC33 homozygous mutant ovaries (Figs. 6B, D) while
Rab7 was neither enriched within, nor excluded from these structures
(Fig. 6F). The distribution of the Rab5 effector Rabenosyn-5 (Tanaka
and Nakamura, 2008) was largely unchanged in Bic-C mutant ovaries
in comparison to controls, and was not enriched or excluded from the
actin spheres in most Bic-C egg chambers (data not shown).
Lastly, we used antibodies speciﬁc for two components of the
exocyst: Sec5 and Sec8. α-Sec5 labels particulate structures through-
out the oocyte cytoplasm in wild-type and heterozygous Bic-C ovaries
(Fig. 6G; Murthy and Schwarz, 2004). However, in Bic-C mutant
ovaries, Sec5 is strongly enriched in and around the F-actin-coated
spheres (Fig. 6H). Sec8 is very strongly enriched around the lateral and
posterior cortex in wild-type oocytes but is present at only low levels
within the oocyte cytoplasm (Beronja et al., 2005). In Bic-C mutant
ovaries, however, Sec8 is clearly enriched within and near the actin-
coated spheres in addition to the oocyte cortex, in a similar manner to
Sec5 (data not shown). This indicates that the actin-coated spheres are
also associated with distinct endosomal markers.
Bic-C associates with multiple components of a Trailer Hitch/Me31B
complex
tral mutant egg chambers display defects in Grk secretion that are
similar to those we observe in Bic-C mutants (Wilhelm et al., 2005).
Furthermore, the identiﬁcation of Me31B both as a component of aTral mRNP complex (Wilhelm et al., 2005) and as a putative Bic-C-
interacting protein (Chicoine et al., 2007), suggests a possible
functional and physical association between Bic-C and Tral-containing
mRNPs. To explore this possibility and conﬁrm our previous ﬁndings,
Me31B-eGFP (Nakamura et al., 2001) was immunoprecipitated from
ovarian extracts with α-GFP and immune complexes were analyzed
bywestern blotting with antibodies speciﬁc to Bic-C and Cup (Fig. 7A).
While Bic-C and Cup are both speciﬁcally enriched in the Me31B-eGFP
immune complex, the interaction between Bic-C and Me31B is more
resistant to RNAse treatment than that of Cup and Me31B (Fig. 7A).
This is consistent with the interaction between Bic-C andMe31B in the
yeast-two-hybrid system (Chicoine et al., 2007) and previous
observations that the Cup-Me31B interaction is RNA-dependent
(Nakamura et al., 2004). We also performed a reciprocal experiment
and found that Me31B-eGFP is speciﬁcally enriched in α-Bic-C
immunoprecipitates (Fig. 7B). To test for an interaction between Bic-C
and Tral, we used α-GFP to isolate immune complexes from Tral-GFP
(Wilhelm et al., 2005) ovarian extracts (Fig. 7C). Western blotting
revealed that Bic-C is speciﬁcally co-precipitated with Tral-GFP and
that this interaction was not strongly affected by RNAse treatment
(Fig. 7C). To determine if Bic-C associates with other components of
Tral-containing RNPs, Bic-C immunoprecipitates from wt ovarian
extracts were analyzed by western blotting with antibodies speciﬁc to
PABP and Cup (Nelson et al., 2004). Both proteins were speciﬁcally
enriched in the Bic-C immune complex in an RNA-dependent manner
(Fig. 7D). Taken together, these results demonstrate that Bic-C
associates with a Tral/Me31B-containing RNP complex.
Bic-C co-localizes with Tral-GFP and Me31B-eGFP in vivo and both
proteins display an altered distribution in Bic-C mutants
To gain additional evidence that Bic-C associates with Tral and
Me31B in vivo, we immunolabelled ovaries expressing Tral-GFP or
Me31B-eGFP with α-Bic-C. In wt stage 10a egg chambers, Bic-C is
expressed throughout the nurse cell and oocyte cytoplasm, and is
particularly concentrated into structures that demonstrate striking co-
localizationwith Tral-GFP (Fig. 8A). These Bic-C positive structures are
Fig. 8. Bic-C co-localizes Tral and Me31B during oogenesis and both proteins are mis-localized in Bic-C mutants. Immunoﬂuorescently labelled Bic-C (red) partially co-localizes with
Tral-GFP (green) throughout the nurse cell and oocyte cytoplasm of a late stage 9/early stage 10 egg chamber (A, see arrows), and with Me31B-eGFP (green) in the oocyte cytoplasm
during mid-oogenesis (B, see arrows). Thirty (C, D) or forty (E, F) 1 μM confocal sections were merged to visualize Tral-GFP (C, D) and Me31B-eGFP (E, F) distribution in Bic-C
heterozygous controls (C, E) and in Bic-C deﬁcient (D, F) ﬁxed stage 8/9 egg chambers. Note that (E) and (F) were taken with identical imaging conditions. (E′) is electronically
brightened to highlight the difference in Me31B-eGFP distribution in comparison with (F).
169J.-M. Kugler et al. / Developmental Biology 328 (2009) 160–172more prominent in Tral-GFP ovaries than in wt, suggesting that
overexpression of Tral recruits additional Bic-C into them. Me31B-
eGFP also accumulates in discrete cytoplasmic foci in both the nurse
cells and the oocyte, which have been shown to co-localize with Tral
throughout much of oogenesis (Fig. 8B, Boag et al., 2005). During mid-
oogenesis, Bic-C is concentrated in the oocyte cytoplasm and its
distribution is granular but more diffuse than that of Me31B. However,
both proteins are clearly enriched together in punctate structures
within the oocyte (Fig. 8B).
We next asked if the distribution of Tral-GFP is altered in the
absence of Bic-C. At stage 8/9, Tral-GFP distribution in Bic-C
heterozygotes is indistinguishable from that in wt egg chambers,
where it displays punctate localization throughout the nurse cell and
oocyte cytoplasm, with some slight enrichment along the anterior
cortex (Fig. 8C). However, in a Bic-C null background, Tral-GFP isreduced in the central portion of the oocyte and is more prominently
concentrated along the anterior and posterior oocyte cortex (Fig. 8D).
Me31B-eGFP is similarly concentrated along the anterior and
posterior cortex in the absence of Bic-C (Fig. 8F). Unlike Tral-GFP,
Me31B-eGFP levels appear to be higher in the Bic-C null background
(Bic-CYC33/Df2LRA5) than in heterozygous Bic-CYC33/+ controls (Figs.
8E, F).
Simultaneous reduction of Bic-C and Tral results in a synergistic
reduction in fertility
If Bic-C and Tral function together in a complex regulating ER
function during oogenesis, a concurrent reduction in the levels of both
proteins might result in a synergistic reduction in fertility. To explore
this possibility we generated trans-heterozygous females bearing
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hypomorphic tral1 P-element insertion or a genomic deletion of the
tral locus (Mahone et al., 1995; Wilhelm et al., 2005). We then
compared the hatching frequency of progeny from these females to
heterozygous controls of either Bic-C or tral mutations alone. We
found that trans-heterozygotes displayed a synergistic reduction in
fertility that, depending on the allelic combination, ranged from 2 to
5.5 fold higher than the additive effects of both alleles (Table 2).
Despite this evident effect on hatching frequency, we only infre-
quently observed strongly ventralized chorions among these progeny,
suggesting that Grk secretion was not strongly perturbed, and we did
not observe obvious defects in Grk localization (data not shown). Since
disruptions in protein trafﬁcking are expected to affect multiple
proteins, this observation might indicate that there are other secreted
maternal factors, required for producing viable oocytes, that are more
limiting than Grk. Alternatively, these mutations may modestly affect
the trafﬁcking of many proteins in addition to Grk, and the collective
effect of doing so may compromise oocyte viability.
Discussion
We present data indicating that loss of Bic-C severely affects Grk-
mediated Egfr activation in the dorsoanterior follicle cells during mid-
oogenesis. We ﬁnd that Grk ectopically accumulates in F-actin coated
spheres that aberrantly form in Bic-Cmutant oocytes. These structures
are enriched in the anterior of Bic-C oocytes and clearly extend beyond
the area of Grk expression. This indicates that the failure to secrete
active Grk is likely to be a consequence of, rather than a cause for, the
formation of these actin-coated structures. The observation that the
actin-coated structures are initially only found in the anterior of the
oocyte correlates well with the anterior enrichment of Bic-C protein in
stage 7–9 oocytes (Saffman et al., 1998). tral mutant egg chambers
display similar defects in Grk secretion, and we provide biochemical
and genetic evidence that Bic-C and Tral interact both physically and
functionally. Tral has been shown to associate with sec13 and sar1
mRNAs which encode COPII exit site components, and tral mutants
display ectopic accumulations of Sar1-GFP throughout the nurse cell
and oocyte cytoplasm, similar to those we observe in the oocyte
cytoplasm of Bic-C mutants (Wilhelm et al., 2005; this study). Taken
together, these observations could suggest that Tral and Bic-C regulate
ER exit site homeostasis and that the F-actin spheres represent an
aberrantly acting exit site compartment which traps proteins,
including Grk, that are destined for secretion. Importantly, the actin-
coated spheres contain only a subset of ER chaperones (BiP and
Calnexin) while excluding several others such as Calreticulin and PDI,
suggesting distinct properties for these various chaperones. This is
consistent with an earlier study indicating that Calnexin and
Calreticulin have distinct activities and substrate speciﬁcities, despite
their extensive similarity (Kleizen and Braakman, 2004), and further
argues that secretion of only a subset of proteins exported from the ER
may be compromised in Bic-C mutants.
We also observe strong accumulation of speciﬁc endosomal Rab
proteins and the exocyst components Sec5 and Sec8 within and near
the actin spheres. Consequently, it appears unlikely that Bic-C is
exclusively involved in COPII exit site formation and suggests
functions for Bic-C in other aspects of the secretory pathway. We
cannot rule out, however, that a primary defect in exit site formation
causes secondary perturbations in other secretory compartments.
Taken together, our analysis of markers for many different steps in
the secretory process indicates that the actin-enriched spheres that
are apparent in Bic-Cmutant oocytes accumulate proteins that would
be present in distinct membrane compartments in wild-type cells.
Perhaps a loss of Bic-C leads to inappropriate fusion of compartments
into the large actin-positive structures we observe. Alternatively, Bic-C
may affect the secretory process at several distinct stages, thus causing
a clustering of endomembrane structures within the actin spheres.The pleiotropic effects of Bic-C on oogenesis are consistent with a
widespread defect in protein secretion. Such a defect would result in a
communication breakdown between the developing oocyte and the
overlying follicle cells, because many signalling molecules, including
Grk, would not efﬁciently reach their target receptors on the follicle
cells, and receptors may not reach the surface of the oocyte to convey
signals back to the germline. Effects on protein secretion could explain
the defective centripetal follicle cell migration observed in Bic-C
mutants (Mahone et al., 1995), since Saxophone, the receptor for Dpp,
is required in the germline for these migratory events to occur
(Twombly et al., 1996). Accordingly, this follicle cell migration
phenotype is rescued through germline-speciﬁc expression of TAP-
Bic-C, indicating that Bic-C functions non-cell autonomously in this
regard. A defect in protein trafﬁcking would also disrupt membrane
growth and/or the localization of adhesion factors, causing the oocyte
to detach from the overlying follicle cell layer, as we have observed in
Bic-C mutants (see Figs. 2B, D). A similar loss of oocyte adhesion has
been observed in mutants of jagunal, which encodes a novel ER
membrane protein required for sub-cortical ER clustering during
oogenesis (Lee and Cooley, 2007).
The underlying cause for the secretory defect in Bic-C mutants
remains uncertain. Bic-C acts as a translational repressor during early
oogenesis and is thought to affect expression of protein from many
mRNAs. We have observed the accumulation of F-actin-coated
spheres in several different Bic-C mutant backgrounds, including
Bic-CRU35 hemizygotes, which bear a point mutation in the third KH-
domain of the protein (Saffman et al., 1998). This mutation weakens
RNA-binding activity in vitro and produces a severe phenotype in vivo
without substantially affecting the level of Bic-C expression (Saffman
et al., 1998), supporting the idea that Bic-C regulates secretion through
an effect on RNA intermediates. Intriguingly, several mRNAs that are
associated with Bic-C encode proteins whose sequence indicates
involvement in vesicular trafﬁcking and/or organization of the actin
cytoskeleton (Chicoine et al., 2007). For instance, CG3279, which was
over 20-fold enriched in Bic-C immunoprecipitates over pre-immune
controls, encodes a protein with a predicted V-SNARE domain,
suggesting a function in mediating vesicular fusion events. Another
putative Bic-C target (12-fold enrichment) is dCip4, whose mamma-
lian homologue interacts with Cdc42, which is involved both in
transport from the ER to the Golgi (Aspenström 1997; Wu et al., 2000;
Nakamura et al., 2008) as well as in retrograde transport from the
Golgi to the ER (Luna et al., 2002). Local regulation of actin dynamics
through Cdc42 is important for vesicular transport between ER and
Golgi (Stamnes, 2002). Aberrant regulation of actin dynamics
associated with vesicular trafﬁcking might explain the formation of
actin-coated spheres in Bic-C mutants and the consequent impaired
secretion of Grk. Although sec13 or sar1 mRNAs, putative targets of
Tral, were not previously found to be enriched in Bic-C immune
complexes (Chicoine et al., 2007), we cannot exclude the possibility
that Bic-C regulates these transcripts in conjunction with Tral, or that
it regulates other transcripts important for vesicular trafﬁcking,
independently of Tral.
Since the abnormalities in Grk localization and accumulation of
actin spheres become apparent when Bic-C mutant egg chambers
appear otherwise morphologically normal, defective microﬁlament
organization and ER exit site formation are likely to be a cause, rather
than an effect, of egg chamber degeneration. In fact, abnormal F-actin
and Grk accumulation are readily detectable at stage 7 in Bic-C
oocytes, providing the ﬁrst evidence that Bic-C has a function, other
than auto-regulation, prior to stage 8 when it is required to suppress
Osk translation (Saffman et al., 1998). Interestingly, Bic-C is not
essential for Grk signalling to the posterior follicle cells at stage 6,
since anterior nuclear migration and cytoskeletal re-polarization,
which are initiated by this signalling event, still occur normally in
most Bic-C mutant egg chambers (data not shown). This is consistent
with reported observations in tralmutants and may be due to a lower
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Egfr activation) in the posterior follicle cells than in the anterior/dorsal
follicle cells.
A subdomain of the ER, marked by Reticulon-like 1 (Rtnl1) protein,
has recently been proposed to act as a transporter and/or anchor for
mRNP complexes containing translationally-repressed mRNAs during
Drosophila oogenesis (Röper, 2007). Interestingly, Rtnl1 co-localizes
with Me31B, Tral and Orb within the oocyte during mid-oogenesis
(Röper, 2007), raising the possibility that Orb may operate in concert
withMe31B and Tral to regulate ER dynamics. It is not knownwhether
Orb plays a role in regulating secretion, since the strongest orb alleles
arrest very early in oogenesis (Lantz et al., 1994; Christerson and
McKearin, 1994). However, in weaker orb mutants, microtubule-
dependent cytoplasmic streaming is initiated prematurely at stage 8
(Martin et al., 2003). Cytoplasmic streaming is normally restricted at
this stage through cross-linking of sub-cortical arrays of micro-
ﬁlaments and microtubules by the actin-binding proteins Cappucino
and Spire, in response to Rho1 signalling (Rosales-Nieves et al., 2006).
Since Bic-C associates with Orb, and antagonizes Orb activity
(Castagnetti and Ephrussi, 2003; Chicoine et al., 2007), it is tempting
to speculate that Bic-C might act through a related mechanism in
regulating microﬁlaments and/or secretion. Future experiments
aimed at determining the effects of Orb overexpression on the ER
and actin cytoskeleton, and the involvement of CCR4-mediated
deadenylation on repression of Tral mRNA targets should help
elucidate the mechanistic basis by which Bic-C, Tral, and associated
proteins act to regulate these structures.
Methods
Microscopy
In situ hybridizations were performed as described by Kobayashi
et al. (1999) except that after initial ﬁxation, samples were
permeabilized and re-ﬁxed as described in method A (without
Proteinase K treatment) of Nagaso et al. (2001). Antibody stainings
were performed as described in Hawkins et al. (1997) for Grk staining,
except H2O2 treatment in methanol was omitted. Primary antibodies
were used at the following concentrations: α-Bic-C, 1:1000; α-Grk,
1:1000; α-β-gal (Sigma), 1:1000; α-Calnexin (Abcam), 1:400; α-BiP
(Imgenex) 1:250; α-Boca, 1:500; α-Sec5, 1:35; α-Sec8, 1:2000; α-
Rab5, 1:1000; α-Rab7, 1:3000; α-Rab11, 1:8000; α-Rabenosyn-5,
1:5000; α-KDEL receptor (Calbiochem) 1:1000; α-GM130 (Abcam)
1:1000. Primary antibodies were detected using Alexaﬂuor-488, -555,
or-596conjugatedantibodies,1:500 (Molecular Probes), afterovernight
pre-adsorption to wt ovaries. DNA and F-actin were visualized by DAPI
and rhodamine-phalloidin (Molecular Probes) staining respectively.
GFP-tagged proteinswere eitherﬁxed for 5–10min in 4% Formaldehyde
in PBS, extensively rinsedwith PBS, 0.3% Triton and counterstainedwith
rhodamine-phalloidin, or dissected into FCS-supplemented Schneider's
S2 cell medium and imaged immediately. Confocal images were
acquired using a Zeiss LSM-510 microscope.
Western blots
Westernblottingwasperformedusing standardmethods (Sambrook
and Russell, 1989). Immunoreactive proteins were detected by chemi-
luminescence (NEN or Perkin Elmer). Dilutions of primary antibodies
were as follows: α-Myc (Invitrogen), 1:1000; α-GFP (clones 7.1/13.1,
Roche), 1:1000; α-Cup, 1:2500; α-PABP, 1:1000; α-Tral, 1:2000.
Immunoprecipitations
Bic-C was immunoprecipitated from Me31B-GFP expressing
ovarian extracts using the method described in Wilhelm et al., 2000,
except that extracts were pre-cleared against protein-A Sepharose(Pharmacia) for 60 min at 4 °C, and after washing, bound proteins
were eluted by boiling in Laemmli sample buffer. For every 10 mg of
soluble ovarian protein extract, 80 μl of α-Bic-C sera or pre-immune
sera (from the same rabbit) was used. The other immunoprecipita-
tions were performed as follows: dissected and ﬂash-frozen ovaries
were homogenized in either mRIPA (for the Tral-GFP IPs: 10 mM Tris,
pH8.0; 150 mM NaCl; 2% Triton X-100; 1% sodium deoxycholate; 0,1%
Nonidet P40 substitute (Fluka); 0.1% SDS; 1 mM PMSF and 1 tablet of
EDTA-free protease inhibitor cocktail (Roche) per 50 ml buffer) or
mDXB (for the Me31B-GFP IPs and the Bic-C IPs: 25 mM HEPES, pH
6.8; 50mMKCl; 1mMMgCl2; 1 mMDTT; 250mM sucrose; 0.1% Triton
X-100; 1mMPMSF and 1 tablet complete EDTA-free protease inhibitor
(Roche) per 50 ml buffer) and centrifuged for 10 min at 20,000 ×g at
4 °C. Extracts were then precleared for 30 min against prewashed
protein A-Sepharose and the supernatant recovered. The protein
concentration was determined by Bradford assays (Biorad) and the
protein concentration adjusted to 1mg/ml. An input aliquot was taken
and boiled 15 min with 2× SDS loading buffer. 1 mg extract was then
added to equivalent amounts of control and IP antibodies [8 μl rabbit
anti-Bic-C or preimmune serum; 12.5 μl mouse anti-GFP (Roche) or
mouse IgG] and rotated at 4 °C for 2–4 h. To control for RNA
dependence, co-immunoprecipitations were performed in the
presence of 100 μg/ml RNaseA. Samples were then precipitated with
15 μl of prewashed protein A-Sepharose beads for 1.5 h at 4 °C. Beads
were then washed three times and bound proteins were eluted by
boiling in 50 μl 1.5× SDS loading buffer.
Generation and expression of TAP-Bic-C
To generate the UASP-TAP-Bic-C construct, sequences encoding the
TAP tag were PCR-ampliﬁed from pZOME-N (Cellzome) and subcloned
into the KpnI site of UASP-Bic-C (Chicoine et al., 2007) to produce an
in-frame fusion with the Bic-C ORF. TAP-Bic-C expression was driven
in ovaries using the nosGal4::VP16 driver (Van Doren et al., 1998).
Genetic interaction assays
For genetic assays, virgin females of the indicated genotypes were
collected for three days prior to mating. After two days of mating, egg
lays were collected at 4 h intervals, on three consecutive days and
hatching frequencies were scored 48 h post-collection. All crosses and
hatching assays were performed at 25 °C.
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